C. Reyes

C. Reyes, E. Nadler, M. Forsyth, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The determinants of recent gains in cancer survival: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database

T. Philipson, A. Jena, D. Goldman, 2008 .

Hospital Rates of Maternal and Neonatal Infection in a Low-Risk Population

C. Hobel, K. Gregory, L. Korst, 2005, Maternal and Child Health Journal.

Patient out-of-pocket payments for oral oncolytics: results from a 2009 US claims data analysis.

C. Reyes, E. Pelletier, Daniel B. Smith, 2012, The American journal of managed care.

Cost-effectiveness of obinutuzumab plus bendamustine followed by obinutuzumab monotherapy for the treatment of follicular lymphoma patients who relapse after or are refractory to a rituximab-containing regimen in the US

D. Veenstra, C. Bernaards, G. Guzauskas, 2018, Journal of medical economics.

Symptoms and toxicity of rituximab maintenance relative to observation following immunochemotherapy in patients with follicular lymphoma

G. Salles, Xiaolei Zhou, C. Copley-Merriman, 2015, Hematology.

Burden of influenza hospitalization among high-risk groups in the United States

Y. Young-Xu, C. Reyes, A. Near, 2021, BMC Health Services Research.

Real-world Effectiveness of Sotrovimab for the Early Treatment of COVID-19 During SARS-CoV-2 Delta and Omicron Waves in the United States

M. C. Maher, C. Reyes, C. Bell, 2022, medRxiv.

Overall Survival and Health Care Costs of Medicare Patients with Previously Treated Chronic Lymphocytic Leukemia

C. Reyes, A. Guérin, S. Shi, 2018 .

Meta-analysis of subcutaneous versus intravenous epoetin in maintenance treatment of anemia in hemodialysis patients.

J. Hornberger, A. Besarab, C. Reyes, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The direct cost and incidence of systemic fungal infections.

J. Beney, C. Reyes, L. Wilson, 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Age distribution of patients with advanced non-melanoma skin cancer in the United States

C. Reyes, Y. Yim, S. Dacosta Byfield, 2013, Archives of Dermatological Research.

Treatment Patterns and Clinical Characteristics of Patients with Advanced Basal Cell Carcinoma in the Community Oncology Setting

C. Reyes, L. Schwartzberg, A. Houts, 2013 .

Frequency and Specificity of Red Blood Cell Alloimmunization in Chilean Transfused Patients

N. Saavedra, C. Reyes, J. Caamaño, 2014, Transfusion Medicine and Hemotherapy.

Assessing health-related quality of life for advanced basal cell carcinoma and basal cell carcinoma nevus syndrome: development of the first disease-specific patient-reported outcome questionnaires.

M. Chren, C. Reyes, S. Fosko, 2014, JAMA dermatology.

Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States

C. Reyes, D. Hurst, Bruno C. Medeiros, 2015, Annals of Hematology.

Innovative Strategies to Reduce Disparities in the Quality of Prenatal Care in Underresourced Settings

V. Hogan, M. Kotelchuck, C. Reyes, 2010, Medical care research and review : MCRR.

The burden of metastatic melanoma: treatment patterns, healthcare use (utilization), and costs

C. Reyes, A. Teitelbaum, R. Linke, 2013, Melanoma research.

Survival and Racial Differences of Non-Small Cell Lung Cancer in the United States Military

C. Carter, C. Reyes, Hans-Peter Goertz, 2015, Journal of General Internal Medicine.

What are the health care costs for chronic lymphocytic leukemia

C. Blauer-Peterson, C. Reyes, M. Matasar, 2017 .

Symptom burden and quality of life in patients with follicular lymphoma undergoing maintenance treatment with rituximab compared with observation

E. Stepanski, C. Reyes, L. Schwartzberg, 2011, Therapeutic advances in hematology.

Treatment patterns and outcomes in BRAF V600E-mutant melanoma patients with brain metastases receiving vemurafenib in the real-world setting

G. Gibney, E. Wu, C. Reyes, 2015, Cancer medicine.

Cost-effectiveness of rituximab as maintenance therapy in patients with follicular non-Hodgkin lymphoma after responding to first-line rituximab plus chemotherapy

J. Hornberger, R. Chien, C. Reyes, 2012, Leukemia & lymphoma.

Economic impact of disease progression in follicular non-Hodgkin lymphoma

R. Beveridge, C. Reyes, K. Sail, 2011, Leukemia & lymphoma.

Economic evaluation of rituximab plus cyclophosphamide, vincristine and prednisolone for advanced follicular lymphoma

D. Lubeck, J. Hornberger, C. Reyes, 2008, Leukemia & lymphoma.

The Association of Rash Severity With Overall Survival: Findings from Patients Receiving Erlotinib for Pancreatic Cancer in the Community Setting

E. Stepanski, C. Reyes, L. Schwartzberg, 2013, Pancreas.

Treatment practice in the elderly patient with chronic lymphocytic leukemia—analysis of the combined SEER and Medicare database

C. Reyes, Khang Q. Hoang, S. Satram-Hoang, 2014, Annals of Hematology.

Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for the treatment of previously untreated chronic lymphocytic leukemia

J. Hornberger, H. Gutierrez, M. Keating, 2012, Leukemia & lymphoma.

Comparative healthcare costs in patients with metastatic melanoma in the USA

V. Schabert, J. Munakata, C. Reyes, 2015, Melanoma research.

Treatment patterns and outcomes among patients with metastatic melanoma treated in community practice

E. Stepanski, C. Reyes, M. Walker, 2014, International journal of dermatology.

Cost-effectiveness analysis of biological treatments for rheumatoid arthritis

C. Chiou, C. Reyes, Julie Choi, 2004, Expert review of pharmacoeconomics & outcomes research.

Gestational Pyelonephritis as an Indicator of the Quality of Ambulatory Maternal Health Care Services

C. Hobel, K. Gregory, L. Korst, 2006, Obstetrics and gynecology.

The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000

T. Philipson, A. Jena, D. Goldman, 2010 .

An Economic Evaluation of the War on Cancer

Tomas Philipson, T. Philipson, A. Jena, 2009, Journal of health economics.

Differences in Treatment Patterns and Health Care Costs among Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia Patients Receiving Rituximab in the Hospital Outpatient Setting versus the Office/Clinic Setting

C. Reyes, L. Becker, S. Byfield, 2014 .

Content validity and psychometric properties of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus©) instrument in patients with COVID-19

M. Kosinski, H. Gelhorn, C. Reyes, 2023, Quality of Life Research.

86. Health Resource Burden of Influenza Among the Elderly with Underlying Conditions in the United States

David K. Hong, Y. Young-Xu, C. Reyes, 2020 .

PIN24 INCIDENCE AND COSTS OF INFLUENZA-RELATED HOSPITALIZATIONS BY COMORBIDITY IN THE UNITED STATES

Y. Young-Xu, C. Reyes, A. Near, 2020 .

Referral and treatment patterns among patients with stages III and IV non-small-cell lung cancer.

S. Ramsey, D. Blough, C. Reyes, 2013, Journal of oncology practice.

Patients' priorities in selecting chronic lymphocytic leukemia treatments.

M. Boeri, C. Mansfield, C. Reyes, 2017, Blood advances.

Acceptability of the contraceptive vaginal ring by rural and urban population in two Latin American countries.

C. Reyes, A. Faúndes, E. Hardy, 1981, Contraception.

What Is the Impact of Comorbidity Burden On Treatment Patterns and Outcomes in Elderly Chronic Lymphocytic Leukemia Patients

C. Reyes, Khang Q. Hoang, S. Satram-Hoang, 2012 .

Budget impact of erlotinib for maintenance therapy in advanced non-small cell lung cancer

D. Veenstra, J. Carlson, C. Reyes, 2011, Journal of medical economics.

263PSurvival gains from advances in first-line systemic therapy for HER2-positive metastatic breast cancer in the U.S., 1995-2015

S. Ramsey, S. Sullivan, J. Roth, 2017 .

Treatment Patterns and Mortality Risk among Elderly Patients with Metastatic Triple Negative Breast Cancer in the United States: An Observational Cohort Study Using SEER-Medicare Data

P. Cortazar, A. Stein, C. Reyes, 2019, Journal of Cancer Therapy.

Budget impact model of adding erlotinib to a regimen of gemcitabine for the treatment of locally advanced, nonresectable or metastatic pancreatic cancer.

D. Lubeck, C. Reyes, M. Danese, 2008, Clinical therapeutics.

Medicare costs and health resource utilisation associated with atrial fibrillation in the elderly

F. Morady, C. Reyes, M. Clark, 2005 .

Comparative clinical and economic outcomes of treatments for refractory non-small cell lung cancer (NSCLC).

Scott D Ramsey, David L Veenstra, Josh J Carlson, 2008, Lung cancer.

The Unmet Need in Chronic Lymphocytic Leukemia: Impact of Comorbidity Burden on Treatment Patterns and Outcomes in Elderly Patients

C. Reyes, Khang Q. Hoang, S. Satram-Hoang, 2013 .

Measuring preference weights for American college of rheumatology response criteria for patients with rheumatoid arthritis.

C. Sherbourne, M. Suarez‐Almazor, M. Weisman, 2005, The Journal of rheumatology.

The impact of the COVID-19 pandemic on diagnoses of common mental health disorders in adults in Catalonia, Spain

E. Burn, C. Reyes, A. Berenguera, 2021, medRxiv.

Comparative Effectiveness of Chemotherapy in Elderly Patients with Metastatic Colorectal Cancer

C. Reyes, S. Satram-Hoang, E. McKenna, 2012, Journal of Gastrointestinal Cancer.

Real-World Health Care Utilization and Costs Among Patients Newly Initiating Systemic Therapy for Chronic Lymphocytic Leukemia (CLL) in the United States

C. Blauer-Peterson, C. Reyes, M. Matasar, 2016 .

A Framework for the Development of maternal quality of care indicators.

C. Hobel, K. Gregory, L. Korst, 2005, Maternal and Child Health Journal.

Increased Mortality Risk among Early Stage Hormone Receptor Positive Breast Cancer Patients Who Did Not Receive Adjuvant or Neoadjuvant Therapy

P. Cortazar, A. Stein, C. Reyes, 2019, Journal of Cancer Therapy.

Development and Validation of a Clinical Risk Score to Predict Hospitalization Within 30 Days of Coronavirus Disease 2019 Diagnosis

Y. Young-Xu, C. Reyes, Jeremy Smith, 2021, Military medicine.

Sensitivity of Administrative Claims to Identify Incident Cases of Lung Cancer: A Comparison of 3 Health Plans

S. Ramsey, D. Blough, C. Reyes, 2009, Journal of managed care pharmacy : JMCP.

Second- and third-line treatment of patients with non-small-cell lung cancer with erlotinib in the community setting: retrospective study of patient healthcare utilization and symptom burden.

E. Stepanski, C. Reyes, L. Schwartzberg, 2009, Clinical lung cancer.

How are quality of life and work productivity associated with living longer with HER2+ metastatic breast cancer?

D. Tripathy, M. Sussman, S. Hurvitz, 2017 .

Original article Budget impact of erlotinib for maintenance therapy in advanced non-small cell lung cancer

D. Veenstra, J. Carlson, C. Reyes, 2011 .

Cost-effectiveness analysis of biological treatments for rheumatoid arthritis

C. Chiou, C. Reyes, Julie Choi, 2004, Expert review of pharmacoeconomics & outcomes research.

Which patient characteristics drive treatment decisions in elderly patients with early stage hormone receptor–positive breast cancer?

P. Cortazar, A. Stein, C. Reyes, 2017 .

Comparative health care (HC) costs in patients (pts) with metastatic melanoma (mM).

V. Schabert, J. Munakata, C. Reyes, 2014 .